Hybrid Membrane-Derived Nanoparticles for Isoliquiritin Enhanced Glioma Therapy
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph15091059
Abstract: Due to the obstruction and heterogeneity of the blood-brain barrier, the clinical treatment of glioma has been extremely difficult. Isoliquiritigenin (ISL) exhibits antitumor effects, but its low solubility and bioavailability limit its application potential. Herein,… read more here.
Keywords: derived nanoparticles; hybrid membrane; membrane derived; membrane ... See more keywords